Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Conditions
Interventions
Intervention1: Co-enzyme Q10 200mg along with Topical Kenacort 0.1%: CoQ10 is an antioxidant drug and Kenacort is a corticosteroid both are approved by FDA
Control Intervention1: Topical kenacort O.1%
Sponsors
Dr Amita Aditya
Dr Radhika Sasikumar
Eligibility
Inclusion criteria
Inclusion criteria: patients who are clinically diagnosed with Oral Lichen Planus using modified WHO criteria, and with symptoms like burning and/or itching. also patient who gives consent for the trial.
Exclusion criteria
Exclusion criteria: patient who is taking systemic steroids, or other immunosuppressive therapies for at least 8 weeks before the study.Patient treated with any oral topical medications for at least four weeks before the study.Patient treated with any oral topical medications for at least four weeks before the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A patient who is under CoQ10 along with Topical Corticosteroids shows a decrease in burning sensation and will be recorded using VASTimepoint: baseline, 48hrs, 1 week, 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| lesion size improvement using thongprasom scaleTimepoint: baseline, 48hrs, 1 week, 4 weeks | — |
Countries
India
Contacts
Public ContactDr Radhika Sasikumar
Dr D Y patil dental College and hospital, Dr D Y patil Vidyapeeth
Outcome results
None listed